WHO ICTRP trial
A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the…
ChiCTR2000035771 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000035771 |
|---|---|
| Public title | A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of ARDS |
| Scientific title | A Phase I Clinical Study on the Safety and Efficacy of Allogeneic Human Adipose-derived Mesenchymal Stem Cell Exosomes (haMSC-Exos) Nebulized Inhalation in the Treatment of Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) |
| Primary sponsor | Ruijin Hospital affiliated Shanghai Jiao Tong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Acute Respiratory Distress Syndrome |
| Interventions | haMSC-Exos low-dose group:7 times aerosol inhalation of haMSC-Exos (2.0*108 nano vesicles/3 ml at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7);haMSC-Exos medium-dose group:7 times aerosol inhalation of haMSC-Exos (8.0*108 nano… |
| Registration date | Aug 16, 2020 |
| Target size | haMSC-Exos low-dose group:3;haMSC-Exos medium-dose group:3;haMSC-Exos high-dose… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: